The Official Website of
The Vascular Society of New Jersey
New Jersey's Professional Association for Vascular Surgeons
You Are Cordially Invited to
The Vascular Society of New Jersey
43rd Annual Scientific Meeting
May 12, 2021
Virtual Annual Meeting and Scientific Meeting
Welcome and Introductions
Sponsor promos and information
Introduction and Business Meeting
Combiz Rezayet, MD VSNJ President
Election of 2021-2023 VSNJ Board of Directors
Scientific Meeting begins
Welcome - Dr. William Beckerman
Alan Lumsden, MD Houston Methodist Hospital
Medical Education in the 21st Century
Hobson Competition Resident Presentations
Robert Thompson, MD Washington University of St. Louis
Contemporary Management of Thoracic Outlet Syndromes
Hobson Competition Award Winner Presentation
Closing Remarks and Adjournment
Alissa Brotman – O’Neill, DO VSNJ President
Please join us for our first virtual Annual & Scientific Meeting.
TARGET AUDIENCE
Vascular surgeons, nurses, and technicians.
CERTIFICATION
Atlantic Health System designates this live educational activity for a maximum of 3.25 AMA PRA Category 1 CreditsÔ. Physicians should claim credit commensurate with the extent of their participation in the activity.
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements of the Medical Society of New Jersey through the joint providership of Atlantic Health System and the Vascular Society of New Jersey. Atlantic Health System designates this live educational activity for a maximum of 4 AMA PRA Category 1 CreditsÔ. Physicians should claim credit commensurate with the extent of their participation in the activity. Atlantic Health System is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians.
DISCLOSURE
It is the policy of Atlantic Health System to ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All participating are expected to disclose to the program audiences any associated or apparent conflict(s) of interest related to the content of their presentation(s). Also disclosed will be any expected discussions of non-FDA-approved products or devices.